메뉴 건너뛰기




Volumn 117, Issue 13, 2011, Pages 3699-3701

Dysregulation of the HIF pathway due to VHL mutation causing severe erythrocytosis and pulmonary arterial hypertension

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CYCLOHEXIMIDE; DIURETIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR; MUTANT PROTEIN; NITRIC OXIDE; PROSTACYCLIN; SILDENAFIL; VASODILATOR AGENT; VON HIPPEL LINDAU PROTEIN;

EID: 79953695043     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-12-327569     Document Type: Letter
Times cited : (40)

References (9)
  • 3
    • 38049173572 scopus 로고    scopus 로고
    • A gain-of-function mutation in the HIF2A gene in familial erythrocytosis
    • Percy MJ, Furlow PW, Luca GS, et al. A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. N Engl J Med. 2008;358(2):162-168.
    • (2008) N Engl J Med , vol.358 , Issue.2 , pp. 162-168
    • Percy, M.J.1    Furlow, P.W.2    Luca, G.S.3
  • 5
    • 33746398489 scopus 로고    scopus 로고
    • Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology
    • Smith TG, Brooks JT, Balanos GM, et al. Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med. 2006;3(7):e290.
    • (2006) PLoS Med , vol.3 , Issue.7
    • Smith, T.G.1    Brooks, J.T.2    Balanos, G.M.3
  • 6
    • 77949725833 scopus 로고    scopus 로고
    • The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice
    • Hickey MM, Richardson T, Wang T, et al. The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice. J Clin Invest. 2010;120(3):827-839.
    • (2010) J Clin Invest , vol.120 , Issue.3 , pp. 827-839
    • Hickey, M.M.1    Richardson, T.2    Wang, T.3
  • 7
    • 50949133897 scopus 로고    scopus 로고
    • Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2alpha mutation
    • Gale DP, Harten SK, Reid CD, Tuddenham EG, Maxwell PH. Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2alpha mutation. Blood. 2008;112(3):919-921.
    • (2008) Blood , vol.112 , Issue.3 , pp. 919-921
    • Gale, D.P.1    Harten, S.K.2    Reid, C.D.3    Tuddenham, E.G.4    Maxwell, P.H.5
  • 8
    • 33644614520 scopus 로고    scopus 로고
    • HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
    • Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006;3(3):177-185.
    • (2006) Cell Metab , vol.3 , Issue.3 , pp. 177-185
    • Kim, J.W.1    Tchernyshyov, I.2    Semenza, G.L.3    Dang, C.V.4
  • 9
    • 35448961940 scopus 로고    scopus 로고
    • HIF-1 mediates the Warburg effect in clear cell renal carcinoma
    • DOI 10.1007/s10863-007-9081-2, Special Topic: The Warburg Effect: Its Continued Impact on Cancer Research into the 21st Century
    • Semenza GL. HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr. 2007;39(3):231-234. (Pubitemid 47619375)
    • (2007) Journal of Bioenergetics and Biomembranes , vol.39 , Issue.3 , pp. 231-234
    • Semenza, G.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.